.png)
T cells are a component of the immune system that the body uses to combat cancer and other illnesses. Genetically altered T cells are known as chimeric antigen receptor T (CAR T) cells. Using the ability of altered T cells to locate and eradicate cancer cells, CAR T cell therapy improves the body's natural barriers against the illness. In the fight against a variety of diseases, such as lymphomas, leukaemia, and several recurring blood cancers, this contemporary type of immunotherapy shows promise.
The United States Food and Drug Administration (USFDA) has authorized CAR T cell treatment for haematological malignancies. To prevent cancer from spreading both initially and over time, CAR T lymphocytes recognize and destroy cancer cells within a patient's body.
